Large Clinical Trial Testing Combination Monoclonal Antibody Therapy for Mild/Moderate COVID-19

A Phase 2/3 clinical trial has begun to evaluate a combination investigational monoclonal antibody therapy for its safety and efficacy in people who have mild...
The post Large Clinical Trial Testing Combination Monoclonal Antibody Therapy for Mild/Moderate COVID-19 appeared first on SciTechDaily.